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Functional Null Mutations of MSRB3
Encoding Methionine Sulfoxide Reductase
Are Associated with Human Deafness DFNB74
Zubair M. Ahmed,1,2,10 Rizwan Yousaf,1,4,10 Byung Cheon Lee,3 Shaheen N. Khan,4 Sue Lee,5
Kwanghyuk Lee,6 Tayyab Husnain,4 Atteeq Ur Rehman,4,5 Sarah Bonneux,7 Muhammad Ansar,8
Wasim Ahmad,8 Suzanne M. Leal,6 Vadim N. Gladyshev,3 Inna A. Belyantseva,5 Guy Van Camp,7
Sheikh Riazuddin,9 Thomas B. Friedman,5 and Saima Riazuddin1,2,*
The DFNB74 locus for autosomal-recessive, nonsyndromic deafness segregating in three families was previously mapped to a 5.36 Mb
interval on chromosome 12q14.2-q15. Subsequently, we ascertained five additional consanguineous families in which deafness segre-
gated with markers at this locus and refined the critical interval to 2.31 Mb. We then sequenced the protein-coding exons of 18 genes in
this interval. The affected individuals of six apparently unrelated families were homozygous for the same transversion (c.265T>G) in
MSRB3, which encodes a zinc-containing methionine sulfoxide reductase B3. c.265T>G results in a substitution of glycine for cysteine
(p.Cys89Gly), and this substitution cosegregates with deafness in the six DFNB74 families. This cysteine residue of MSRB3 is conserved
in orthologs from yeast to humans and is involved in binding structural zinc. In vitro, p.Cys89Gly abolished zinc binding and MSRB3
enzymatic activity, indicating that p.Cys89Gly is a loss-of-function allele. The affected individuals in two other families were homozy-
gous for a transition mutation (c.55T>C), which results in a nonsense mutation (p.Arg19X) in alternatively spliced exon 3, encoding
a mitochondrial localization signal. This finding suggests that DFNB74 deafness is due to a mitochondrial dysfunction. In a cohort of
1,040 individuals (aged 53–67 years) of European ancestry, we found no association between 17 tagSNPs for MSRB3 and age-related
hearing loss. MouseMsrb3 is expressed widely. In the inner ear, it is found in the sensory epithelium of the organ of Corti and vestibular
end organs as well as in cells of the spiral ganglion. Taken together, MSRB3-catalyzed reduction of methionine sulfoxides to methionine
is essential for hearing.Introduction
Genetic studies have uncovered numerous proteins essen-
tial for hearing.1–3 Although mutations of ubiquitously ex-
pressed genes would not be expected to be associated with
nonsyndromic deafness, there are now several such exam-
ples, including mutations of the genes encoding g-actin
(MIM 102560),4–6 taperin (MIM 613354),7 protocadherin-
15 (MIM 605514),8 tricellulin (MIM 610572),9 and DFNA5
(MIM 608798).10 Given the sometimes surprising nature
of the genes mutated in nonsyndromic deafness, linkage
analysis performed in large families remains a powerful
method for identifying components necessary for hearing.
Markers at 86 distinct genetic-deafness loci that are in-
herited as a recessive trait (DFNB loci; MIM 220700) have
now been linked to hearing loss in family studies. To date,
the genes have been identified for only 38 of these DFNB
loci (Hereditary Hearing Loss Homepage).1,11
Using a genome-wide linkage analysis, we mapped
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The Amsome12q14.2-q15.12 Recently, we ascertained an addi-
tional five families (PKDF805, PKSR3b, PKB02, 4258,
and 4259) in which deafness segregated with markers at
this locus. Here, we report the results of a mutation screen
to identify the mutated DFNB74 gene. We examined the
coding and flanking intronic sequence of every gene in
the refined linkage interval. We found two mutations (a
missense null allele and a premature stop codon) in
MSRB3, encoding methionine sulfoxide reductase B3.
The missense mutation (p.Cys89Gly) segregated in six
apparently unrelated DFNB74 families, whereas the
nonsense mutation (p.Arg19X) was found in two addi-
tional consanguineous Pakistani families. In vitro, studies
support the hypothesis that p.Cys89Gly is also a loss-of-
function allele and abolishes the enzymatic activity and
Zn2þ binding ability of MSRB3. The p.Arg19X mutation
is located within alternatively spliced exon 3, encoding
the mitochondrial localization signal. These suggest that
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protein-bound and/or free methionine sulfoxides arising
from oxidative stress.Subjects and Methods
Family Ascertainment and Phenotype Analysis
This study was approved by institutional review board (IRB) at the
National Centre of Excellence in Molecular Biology (NCEMB), La-
hore, Pakistan (FWA00001758), the Combined Neuroscience IRB
at the National Institutes of Health, USA (OH-93-N-016), the IRB
Committee at theCincinnatiChildren’sHospital Research Founda-
tion,USA (2009-0684), the IRBatBaylorCollegeofMedicine,Hous-
ton, TX, USA, and the IRB at Quaid-i-Azam University, Islamabad,
Pakistan. Written informed consent was obtained from adult
subjects and parents of minor subjects. Participating subjects
were evaluatedbymedical-history interviews, and aphysical exam-
ination was performed on two hearing-impaired individuals from
each family. The degree of hearing loss was assessed by pure-tone
audiometry involving air conduction (frequencies ranged from
250–8000 Hz). We assessed facial nerve function by looking for
symmetrical facial expressions. Vestibular function was evaluated
by tandem-gait andRomberg testing.Adetailed funduscopic exam-
ination of some affected individuals ruled out frank retinopathy.
Dental examinationswere performed in some of theDFNB74 fami-
lies so that toothdevelopment couldbe evaluated. Peripheral blood
samples or buccal swabs were collected from each participating
subject for genomic DNA extraction.Candidate-Gene Screening
The 18 genes within the DFNB74 refined linkage interval were
screened for mutations by direct sequencing of PCR products
generated from genomic DNA from two affected individuals of
four DFNB74 families (PKDF326, PKDF528, PKDF805, and
PKDF859; Table S1, available online). Primers were designed
with Primer3 software for amplification of all exons, including
exon-intron boundaries, of each candidate gene. Primer pairs
used for the amplification of MSRB3 exons are listed in Table S2.
Methods for direct sequencing and mutational analyses were
described previously.9 Cosegregation of the mutations with deaf-
ness in each DFNB74 family was confirmed by direct sequencing
of the PCR products amplified from the genomic DNA of all the
participating family members. Control DNA samples from ethni-
cally matched Pakistani population were sequenced for mutant
alleles in exons 3 and 4 of MSRB3.MSRB3/Msrb3 Expression Analyses
MSRB3 isoforms A and B (RefSeq NM_198080.3 and
NM_001031679.2, respectively) were amplified from human
multi-tissue cDNA panels (Clontech MTC human panels I and
II) and from a human retina cDNA library (Genemed). The PCR
primers (forward, 50-CTGCCTGGCCTTTCCATGAG-30; reverse,
50-ACAATGGAGTTCCACAAACAACACA-30) are located in exons
1 and 4, respectively.
Msrb3 (RefSeq NM_177092.4), the mouse ortholog of human
MSRB3, was amplified from two mouse multi-tissue cDNA panels
(Clontech MTC Panels I and III) and from mouse cochlear cDNA
libraries that were prepared with a SMART kit and oligo-dT primers
(Clontech). The PCR primers (forward, 50- CTTTGCCTCTGC
TGGAGATACCAC-30; reverse, 50-AACGGAGTTCCACAGACAACA
CATT-30) are located in exons 2 and 4, respectively.20 The American Journal of Human Genetics 88, 19–29, January 7 , 2For relative quantitative analysis of Msrb3, the PCR primers
(forward, 50-TTGTCTGTGGAACTCCGTTG-30; reverse, 50-CCCGTA
GGAAAAGTCATCTGTG-30) were located in exons 4 and 6, and the
probe (50- TCTGGTTCAGGCTGGC-30) spanned the junction of
exons 5 and 6.Fluorescently Tagged MSRB3 Expression Constructs
EGFP-tagged humanMSRB3 isoform A (IsoA_WT) was constructed
with PCR primers (forward, 50-AGTGATGTCTGCATTCAACCTGC
TG-30; reverse, 50-GAGCTCCGCTTTGTCTGCCTGG-30) located in
exons 1a and 8, respectively, and a brain cDNA library (Clontech)
was used as the source of the template. The cloned and sequence-
verified product was inserted into pEGFP-N2 (Clontech). An
expression vector of humanMSRB3 isoform B (IsoB_WT) was con-
structed with a forward primer 50-GCTGCCTGGCCTTTCCAT
GAG-30 located in exon 3 and a reverse primer 50-GAGCTCCGC
TTTGTCTGCCTGG-30 located in exon 8. Constructs encoding
p.Cys89Gly mutant MSRB3 that also included a C-terminal
EGFP tag were prepared through site-directed mutagenesis for
which wild-type MSRB3 IsoA_WT and MSRB3 IsoB_WT were
used as templates.Immunoblot Analysis
For protein blot analyses, cochlea of postnatal day 7 (P7), P15, P42,
and P60 C57BL/6J mice, as well as P42 vestibule, P7 heart, and P7
liver, were homogenized in ice-cold protease inhibitor cocktail
(Calbiochem Biosciences) with a mechanical homogenizer (Fisher
Scientific). Homogenates were boiled for 5 min in SDS-PAGE
sample buffer (0.125 M Tris-HCl, 20% glycerol, 4% SDS, and
0.005% bromophenol blue). Fifty milligrams of protein in the
samplewas separated on a 10% Bis-Tris acrylamide gel (Invitrogen)
with Novex Sharp protein standards (Invitrogen) and transferred
to PVDF membrane (Millipore) for immunoblot analyses as
described previously.13Antibodies
Antiserum raised in rabbits against human MSRB3 was obtained
from Sigma-Aldrich (HPA014432) and used for immunoblot and
indirect immunofluorecence analyses. The human MSRB3 re-
combinant protein epitope used for raising this commercial anti-
serum (100 residues) is 97% identical and 99% similar to mouse
MSRB3 (data not shown). To validate the anti-MSRB3 antibody
(HPA014432; Sigma), we performed a colocalization assay by using
expression vectors encoding EGFP-tagged human and mouse
MSRB3 isoforms transfected with FuGene 6 (Roche) or by electro-
poration (Invitrogen) into COS7 cells. The cells were grown on
coverslips in Dulbecco’s modified Eagle’s medium (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen). After
incubation at 37C with 5% CO2 for 24 hr, transfected COS7 cells
were fixed with 4% paraformaldehyde (PFA) for 20 min and per-
meabilized for 7 min in 0.5% Triton X-100. Nonspecific binding
sites were blocked by incubation in blocking solution (2% BSA
and 5% normal goat serum in PBS) for 30 min. Primary MSRB3
antibody was diluted in blocking solution to a final concentration
of ~5 mg per ml. Cells were incubated with MSRB3 antibody for
2 hr at room temperature, and incubation with conjugated goat
anti-rabbit IgG secondary antibodies (Molecular Probes) followed
for 20 min. As a marker of the endoplasmic reticulum, anti-
calregulin antibody (Santa Cruz) was used at a 1:500 dilution.
Samples were washed in PBS, mounted with ProLong Gold
Reagent (Molecular Probes), and imaged with either a Zeiss Axio011
Imager Z1microscope equipped with apotome grids or an LSM710
Zeiss confocal microscope.
For experiments involving mice, prior approval was obtained
from the Animal Care and Use Committees (protocol 9B06047)
at Cincinnati Children’s Hospital Medical Center and at the
National Institute on Deafness and Other Communication Disor-
ders, National Institutes of Health (protocol 1263-09). Inner ears
from P2 and adult C57BL6/J mice were fixed with 4% PFA at
room temperature for 2 hr and washed with phosphate-buffered
saline (PBS). The organs of Corti and vestibular sensory epithelia
were dissected in PBS. After permeabilization with 0.5% Triton
X-100 for 30 min, samples were incubated in blocking solution
(5% normal goat serum and 2% bovine serum albumin [ICN] in
PBS) so that the nonspecific binding sites would be blocked.
Samples were then incubated for 2 hr in anti-MSRB3 antibody at
~5 ug/ml in blocking solution. This was followed by three washes
in PBS and consecutive incubation with FITC-conjugated anti-
rabbit IgG secondary antibody (Molecular Probes) at 1:500 dilu-
tion and with rhodamine-phalloidin at 1:100 dilution in blocking
solution for 20 min. After three washes with PBS, samples were
mounted via ProLong Gold Antifade Reagent (Molecular Probes)
and viewed with an LSM710 confocal microscope (Carl Zeiss Mi-
croimaging Inc.).
Cloning, Expression, and Purification of Wild-Type
and Mutant MSRB3
A construct encoding p.Cys89Gly mutant MSRB3 containing a
C-terminal His tag (LEHHHHHH) was prepared through site-
directed mutagenesis with the MSRB3AD construct that lacks
sequence for residues 1–3114 encoding the endoplasmic reticulum
targeting sequence. The sequences of wild-type and mutant
constructs were verified, and the constructs were expressed in
E. coli BL21(DE3) and subsequently purified with a QIAGEN nickel
column and concentrated with the Ultracel-10K filters (Millipore).
The purity of the purified proteins was analyzed on a 3%–8%
Novex-PAGE (Invitrogen).
Determination of MSRB3 Activity and Zn Binding
The reaction mixture used for measuring the MSRB3 enzymatic
activity (100 ml in PBS [pH 7.4]) includes 20 mM dithiothreitol
(DTT) and 200 mM dabsyl-methionine-R-sulfoxide. The reaction
was initiated by the addition of 5 mg of purified wild-type or
p.Cys89Gly mutant MSRB3 protein, allowed to proceed at 37C
for 30 min, and then stopped by the addition of 200 ml of acetoni-
trile. After centrifugation at 4C for 15 min at 16,200 3 g, the
supernatant (50 ul) was injected onto a C18 column (ZORBAX
Eclipse XDB-C18) so that dabsyl-methionine could be quantified
via HPLC as described previously.15
In order to analyze Zn binding to MSRB3, we performed
elemental analysis of Zn with an inductively coupled plasma
mass spectroscopy (ICP-MS) (UNL Redox Biology Center, Lincoln,
NE) by using an Agilent 7500cx operating with a collision reaction
cell filled with 3.5 ml/min of hydrogen and 1.5 ml/min of Argon.
Association Studies
A set of 1040 independent samples from Belgian volunteers aged
53–67 years, collected as part of a larger study and described in
detail previously,16,17 was used for this study. All individuals filled
in a detailed questionnaire on health and environmental factors,
and individuals suffering from diseases known to affect hearing
were excluded. For selected volunteers, pure-tone audiometry
was performed at 0.125, 0.25, 0.5, 1, 2, 3, 4, 6, and 8 kHz for airThe Amconduction and at 0.5, 1, 2, and 4 kHz for bone conduction. Indi-
viduals suffering from asymmetric hearing loss or conductive
hearing loss were excluded. Several age- and sex-corrected audio-
logical measures representing the hearing ability of these individ-
uals were calculated on the basis of the pure-tone audiometry data.
The measures included Z scores for high frequencies18 and the
three main principal components (PCs).19
Zhigh scores were calculated for the best-hearing ear as described
previously.18 In brief, frequency-specific thresholds were con-
verted to sex- and age-independent Z scores based on the ISO
7029 standard. These Z scores represent the number of standard
deviations that actual hearing threshold differs from the median
of the standard at a given frequency. As a measure of high-
frequency hearing impairment, the Z scores at 2, 4, and 8 kHz
were averaged (Zhigh). Although Zhigh is a good at describing an
individual’s hearing acuity, it ignores essential parts of the infor-
mation contained in an audiogram. For instance, different audio-
metric shapes can result in a similar Zhigh. The use of PCs enabled
us to extract additional information, including information
related to the shape of the audiogram, from the audiometric
data. We performed the calculation of PCs as described previ-
ously.19 Only values from six frequencies (0.250, 0.5, 1, 2, 4, and
8 kHz) from the best ear, defined as the ear with the lowest average
threshold over all frequencies, were used. We removed effects of
age and gender by regressing the log-transformed threshold values
on age, age squared, and age cubed in males and females sepa-
rately. The residuals of each regressionwere scaled to 1, after which
values for males and females were combined. Subsequently, a clas-
sical principal-component analysis was carried out on the multi-
variate phenotype. We only retained the first three PCs, capturing
more than 80% of the variability of the phenotype. PC1 can be
considered a ‘‘size’’ variable, providing an overall measure of
a subject’s hearing ability. PC2 and PC3 should be regarded as
‘‘shape’’ variables. PC2 contrasts low with high frequencies and
is a measure of the slope of the audiogram. PC3 contrasts the
middle frequencies with the lower and higher frequencies and
can be considered a measure of the concavity of an audiogram.
In order to capture most of the genetic variation of MSRB3, we
selected 17 tagSNPs on the basis of the HAPMAP data of MSRB3
by using the default setting (r2 ¼ 0.8) of the Haploview’s Tagger
software. KBioscience (Hoddesdon Herts, UK) genotyped these
SNPs by using fluorescence-based competitive allele-specific PCR
(KASPar). After checking for deviation from Hardy-Weinberg equi-
librium for each individual SNP, we performed an association test
between Zhigh, the three principal components, and each MSRB3
tagSNP by using linear regression with SPSS 15.0 for Windows
(SPSS inc., Chicago, Illinois, USA).Results
Clinical Findings
This study reports on three Pakistani families (PKDF326,
PKDF528, and PKDF859) in which profound hearing loss
was found to be linked to a 5.35 cM interval on human
chromosome 12q14.2-q15. The locus was designated
DFNB74.12 Subsequently, we screened genomic DNA from
family members with nonsyndromic hearing loss by using
microsatellite markers at the DFNB74 locus and identified
five more DFNB74 families (PKDF805, PKB02, PKSR3b,
4258, and 4259). The affected individuals of DFNB74erican Journal of Human Genetics 88, 19–29, January 7 , 2011 21
Figure 1. Substitution of a Conserved Cysteine Residue of MSRB3 Causes Nonsyndromic Hearing Loss DFNB74
(A) Pedigrees of three of the six DFNB74 families affected by prelingual nonsyndromic sensorineural hearing loss associated with the
p.Cys89Gly alteration of MSRB3. Filled symbols represent individuals with prelingual severe to profound hearing loss, and a double
horizontal line indicates a consanguineous marriage. Haplotype data for family PKDF805 (individual VI:12) provided a refined distal
genetic recombination (red arrow head), and a proximal recombination breakpoint was identified in family PKDF529 (LOD 5.63,
D12S313), as reported.12
(B) Nucleotide sequence chromatograms of part of exon 4 ofMSRB3 show the wild-type sequence and homozygosity for the c.265T>G
transversion mutation.
(C) The cysteine residue at amino acid position 89 (accession number NP_932346.1) is completely conserved across a wide variety of
species. Identical residues are in red.families, for which clinical data are available (PKDF805,
PKDF859, PKDF528, PKDF326; 4258; 4259) are bilaterally
profoundly deaf across all tested frequencies, and hearing
loss began before the age of language acquisition. Some obli-
gate carriers and noncarrier individuals in some of these
families were tested for hearing and have normal hearing
thresholds.Also,wedidnot observe any signof earlyhearing
loss in heterozygous individuals examined in our DFNB74
families. Although rigorous testing could not be done in
Pakistan, vestibular function appeared normal. Other evalu-
ations revealed no obvious skin, auricular, or dental abnor-
malities. Funduscopic examination of two affected individ-22 The American Journal of Human Genetics 88, 19–29, January 7 , 2uals each from families PKDF805, PKDF859, PKDF528, and
PKDF326 showed no indication of retinitis pigmentosa.
Genetic and Physical Map
Genotyping with additional STR markers and DNA
samples from family PKDF528 refined the centromeric
boundary of the DFNB74 locus to D12S1585 (75.76 cM,
63.33 Mb), and a telomeric crossover at STR D12S1702
(77.25 cM, 65.64 Mb) was observed in affected individual
VI:12 of family PKDF805 (Figure 1). If we assume locus
homogeneity, these data reduced the critical linkage
interval from 5.35 cM (5.36 Mb) to 1.49 cM (2.31 Mb)011
Figure 2. Nonsense Mutation of MSRB3 Causes Nonsyndromic
Hearing Loss DFNB74 in Two Consanguineous Pakistani Families
(A) Pedigrees of two apparently unrelated DFNB74 families
affected by prelingual nonsyndromic hearing loss due to a
p.Arg19X nonsense mutation ofMSRB3. Among the affected indi-
viduals of the two families, there is a common haplotype of SNPs
spanning a 15.2 Mb region that includes MSRB3. Physical map
positions are taken from the February 2009 (GRCh37/hg19)
assembly of the Human Genome Browser.
(B) Representative nucleotide sequence chromatograms of part
of exon 3 of MSRB3 show the wild-type and homozygosity for
the c.55C>T (p.Arg19X) transition mutation. Mutation nomen-
clature is according to MSRB3 isoform B (accession number
NM_001031679.2). Exon 3 is alternatively spliced and is absent
from isoform A (Figure 3A), the longest transcript ofMSRB3 (acces-
sion number NP_932346.1).(Figure 1 and Waryah et al.12). There are 18 predicted or
reported genes within or adjacent to the smallest
DFNB74 linkage region: RASSF3 (MIM 607019), GNS
(MIM 607664), TBC1D30, KIAA0984, AK123272, WIF1
(MIM 605186), LEMD3 (MIM 607844), MSRB3, RPSAP52,
HMGA2 (MIM 600698), AK128707, AY387666, LLPH,
TMBIM4, IRAK3 (MIM 604459), HELB, FLJ00057, and
GRIP1 (MIM 604597; hg19 chr12:65,053,673–67,
359,534). We sequenced the coding exons of these 18
genes along with their donor and acceptor splice sites
and approximately 50 bases of flanking intronic sequences
by using the genomic DNA samples from two affected
individuals of each family (PKDF326, PKDF528,
PKDF805, and PKDF859; LOD score above 2.5; Table S1).
Identification of DFNB74
We found ten nucleotide variants in 18 candidate DFNB74
genes, nine of which had been previously reported as
single-nucleotide polymorphisms (SNPs; dbSNP build131).
The only variant not present in dbSNP was c.265T>G,
located in exon 4 of MSRB3 (Figure 1B). This transversion
predicts thesubstitutionofaglycine for a conservedcysteine
at residue 89 (p.Cys89Gly; Figure 1C). This missense muta-
tion cosegregates with hearing loss in six DFNB74 families
(PKDF805, PKDF859, PKDF528, PKDF326, PKB02, and
PKSR3b) and is absent in the 1000 Genomes database of
human genetic variation as well as in 262 genomic DNA
samples (524 control chromosomes) from normal-hearing
Pakistani individuals we analyzed.
To determine whether c.265T>G segregating in these six
DFNB74 families occurs on the same haplotype, we geno-
typed eight SNPs distributed across the 707 kb that flank
c.265T>G (Table S3).We found that all affected individuals
in these six families are homozygous for the same haplo-
type of eight informative SNPs (Table S3), indicating that
this mutation probably arose only once and is now segre-
gating as identical by descent in apparently unrelated
families.
A transition mutation (c.55C>T; NM_001031679.2;
Figure 2B) in the third exon of MSRB3 (Figure 3A) segre-
gates with DFNB74 in two apparently unrelated families
(4258 and 4259; Figure 2A) with suggestive linkage to
markers for DFNB74. The mutation is predicted to replace
arginine at residue 19 with a translation stop codon
(p.Arg19X). This nonsense mutation cosegregates with
hearing loss in both families. Haplotype analysis suggests
a founder allele. c.55C>T was absent in 250 DNA samples
(500 control chromosomes) from normal-hearing Pakis-
tani individuals and in the 1000 Genomes database of
human genetic variation.
MSRB3 and Msrb3 Isoforms and Their Expression
We next examined the gene structure and expression of
MSRB3. There are four alternatively spliced isoforms of
human MSRB3 (Figure 3A). Isoform A (reference sequence
NM_198080.3) has six exons encoding a protein of
192 amino acids.20 Translation of isoform A begins inThe Amexon 1a (Figure 3A). The amino terminus of MSRB3 iso-
form A has a predicted endoplasmic reticulum localization
signal (residues 1–31), whereas the remaining peptide
encodes a methionine sulfoxide reductase (Msr domain)
that catalyzes the reduction of oxidized methionine resi-
dues and thus repairs oxidatively damaged proteins.21
MSRB3 isoforms B, C, and D (NM_001031679.2,
NM_001193460.1, and NM_001193461.1, respectively)
include cassette exon 3, which contains a translation initi-
ation codon (Figure 3A). RNAs of isoforms B and C have in-
frame stop codons upstream of the translation initiation
codon in cassette exon 3. Transcription of isoform D
begins in the isoform-D-specific exon 1b (Figure 3A). Iso-
forms B, C, and D each encode a 185 amino acid protein
(NP_001026849.1) that differs from isoform A only at its
N terminus (Figure S1). Isoforms B, C, and D have anerican Journal of Human Genetics 88, 19–29, January 7 , 2011 23
Figure 3. Transcripts Encoding MSRB3
in Human and Mice and Their Expression
Profile
(A) Alternative splicing leads to four iso-
forms of human MSRB3. MSRB3 isoform
A has translation initiation codon (AUG)
in exon 1a, which is spliced with exons 4
through 8 to encode a polypeptide of 192
amino acids. MSRB3 isoform C includes
exons 1a, 3, and 4–8. The predicted trans-
lation initiation codon for MSRB3 isoform
C is located in exon 3. The predicted open
reading frame for this isoform encodes 185
amino acid residues. MSRB3 isoform B
transcript has all eight exons and utilizes
the translation initiation codon present
in exon 3 and also encodes the same
protein of 185 amino acids. MSRB3 iso-
form D utilizes cassette exon 1b and
encodes a 185 amino acid polypeptide
that is identical to that encoded by iso-
forms B and C. Shown also are the two
mutations found in DFNB74 families.
The numbering of the position of muta-
tion c.265T>G (p.Cys89Gly) is based
on accession number NM_198080.3,
whereas c.55C>T (p.Arg19X) is assigned
on the basis of MSRB3 isoform B
(NM_001031679.2).
(B) HumanMSRB3 isoforms A, B, and C are
expressed in many tissues.
(C) Mice have only a single Msrb3 tran-
script, which is ubiquitously expressed.
(D) Real-time quantitative RT–PCR anal-
ysis of Msrb3 mRNA level in C57BL/6J
mouse temporal bones at 11 different
developmental stages. CT is the observed
threshold number of PCR cycles required
for detection of the amplification product; DCT is the calculated difference in CT between the Msrb3 gene and an internal control stan-
dard (Gapdh) measured in the same sample. DDCT is the calculated difference in DCT between the experimental and P90 time points.
(E) Sigma-Aldrich commercial antiserum raised against human MSRB3 was used for determining the expression of mouse MSRB3 in
immunoblot analysis.identical N terminus that is encoded by exon 3. These
isoforms contain a predicted mitochondrial localization
signal also encoded by exon 3, whereas the remainder of
the protein is identical to isoform A (Figure S1).
The c.265T>G mutation alters all four isoforms of
MSRB3. From these data, we can conclude that the ER or
mitochondrial form of MSRB3, or both, is required for
normal hearing. However, in exon 3 the c.55C>T muta-
tion, predicted to be a nonsense mutation (p.Arg19X),
alters isoforms B, C, and D (Figure 3A), but not isoform
A, indicating that MSRB3 isoforms targeted to mitochon-
dria are essential for hearing. MSRB3 isoforms A and C
are easily detected in cDNA samples prepared from 17
different human tissues (Figure 3B).
In comparison to human MSRB3, mouse Msrb3 has six
coding exons and, from our data from multiple mouse
tissue cDNAs, appears to express only a single isoform (Fig-
ure 3C). Mouse MSRB3 has adjacent sequences for both ER
and mitochondrial localization, and yet it is largely tar-
geted to the ER for unknown reasons.14 Mouse MSRB3 is
91% identical and 94% similar to human MSRB3 isoform
B (Figure S1).24 The American Journal of Human Genetics 88, 19–29, January 7 , 2We assayed expression of C57BL/6J Msrb3 mRNA by
using a TaqMan probe and real-time quantitative RT-PCR
of RNA extracted from temporal bones of embryonic day
15 (E15), E17, postnatal day 0 (P0), P3, P5, P7, P16, P30,
P60, P90, and P180 mice (Figure 3D). Compared to Gapdh
mRNA used as an internal control, Msrb3 mRNA is easily
detectable from E15 to P30, whereas expression appears
to decrease after P30 but is still present in the mouse inner
ear at P180 (Figure 3D).
Localization of MSRB3 in the Mouse Inner Ear
The specificity of MSRB3 antibody was validated in heter-
ologous cells that overexpress EGFP-tagged full-length
human isoform A or B (Figure S3) and by immunoblot
analyses (Figure 3E). MSRB3 antibody recognizes wild-
type EGFP-tagged human isoforms but does not reveal
a detectable level of endogenous MSRB3 in COS7 cells
(Figure S2, arrows). Next, we immunostained the COS7
cells transiently expressing EGFP-tagged full-length wild-
type human MSRB3 and p.Cys89Gly mutant MSRB3 iso-
forms with anti-MSRB3 antibodies. At the lightmicroscopy
level we did not find a difference in the localization of011
Figure 4. MSRB3 Is Localized in the Auditory and Vestibular Sensory Epithelia of the Inner Ear
(A and D) MSRB3 (green) is localized to the outer (OHCs) and inner (IHCs) hair cell bodies. A barely detectable level of MSRB3 was
observed in the hair cell stereocilia. Supporting cells have weaker staining by anti-MSRB3 antibody than hair cells.
(B, E, H, and K) The actin cytoskeleton of the organ of Corti and vestibular sensory epithelia cells is highlighted by rhodamine-phalloidin
(red).
(C, F, I, and L) Merged images.
(G and J) MSRB3 localizes in the vestibular hair cell bodies and also in supporting cells (green). Panel G shows staining at the stereocilia
level. Stereocilia bundle staining is barely detectable, and a weak signal could be observed in the kinocilia (G and I). Note that theMSRB3
signal in hair cells is prominent (J and L). Scale bars in F and L are 20 mm.the wild-type and mutant (c.265T>G) of either the mito-
chondrial or the ER isoforms of human MSRB3 (Figure S3).
Immunolocalization of MSRB3 was examined in the
C57BL/6J mouse organ of Corti and vestibular sensory
epithelium (Figures 4A–4L). Immunoreactivity was found
in the sensory epithelia of the organ of Corti and vestibular
end organs as early as P2 and was detectable in adult miceThe Am(Figures 4A, 4D, 4G, and 4J). In the organ of Corti, MSRB3
was present in inner and outer hair cells and, to a lesser
extent, in supporting cells. Inhair cells,MSRB3 immunoflu-
orescencewas distributed throughout the cell body (Figures
4D and 4F), and therewas a barely detectable level in stereo-
cilia (Figure 4A). MSRB3 immunoreactivity was also
observed in spiral ganglion neurons (Figures S4A–S4D).erican Journal of Human Genetics 88, 19–29, January 7 , 2011 25
Figure 5. Replacement of a Highly Conserved Cysteine Residue
at Position 89 with Glycine Diminishes the Enzymatic Activity as
Well as the Zn-Binding Ability of MSRB3
A construct encodingmutant p.Cys89Gly humanMSRB3 contain-
ing a C-terminal His tag (LEHHHHHH) was prepared through
site-directed mutagenesis with a MSRB3AD (1-31 amino acid)
construct that lacked the endoplasmic-reticulum-targeting
sequence.20
(A) Catalytic activity of the p.Cys89Gly mutant form of MSRB3 is
shown and compared to the activity of the wild-type protein.
Virtually no activity of the p.Cys89Gly mutant of MSRB3 was de-
tected in the DTT-dependent reaction.
(B) A statistically significant reduction in Zn content of the protein
was observed for p.Cys89Gly mutant MSRB3 as compared to the
wild-type protein.
Data are represented as means, and error bars represent standard
deviations. Error bars and standard deviation were calculated on
the basis of three independent experiments.No detectable level of expression was observed in the stria
vascularis when this antibody was used (data not shown).
In the vestibular end organs,MSRB3was found throughout
the sensory epithelium, but more intense expression was
observed in hair cells than in supporting cells (Figures 4J
and 4L). In vestibular hair cells, the most prominent
MSRB3 staining was present within cell bodies (Figures 4J
and 4L), and a weaker signal was observed in kinocilia.
MSRB3 staining in stereocilia was barely detectable (Figures
4G and 4I). No specific immunoreactivity was observed
when the primary antibody was omitted.
p.Cys89Gly Ablates Zn Binding and Enzymatic
Activity
To determine the effect of p.Cys89Gly on Zn binding and
enzymatic activity, we expressed in E. coli the full-length
wild-type and p.Cys89Gly mutant human MSRB3 without
the signal sequence, purified the proteins by using a
C-terminal His tag, and measured enzymatic conversion
of dabsyl-methionine-R-sulfoxide to dabsyl-methionine
in the presence of dithiothreitol (DTT).22 In comparison
to wild-type MSRB3, p.Cys89Gly virtually eliminated all
enzymatic activity and Zn2þ binding ability of MSRB3
(Figures 5A and 5B).
MSRB3 and Age-Related Hearing Loss
Interestingly, early-onset, rapidly progressing hearing loss
in A/J mice (ahl4) was mapped to chromosome 10 in
a region of conserved synteny with the DFNB74 locus.
We suggested that ahl4 and DFNB74 might result from
mutations of orthologous genes.23 Bioinformatic analyses
of genomic sequences of Msrb3 exons, 50 bp of flanking
introns, and approximately 5,000 bp upstream of exon 1
in ten inbred mouse strains including A/J did not reveal
an A/J (ahl4)-specific variant of Msrb3, indicating that an
alteration of Msrb3 is probably not responsible for the
murine ahl4 phenotype.23
We next explored the possibility that a variant associated
with humanMSRB3might make a significant contribution
to age-related hearing loss (AHL). Sixty percent of people
between the ages of 71 and 80 have some hearing loss.24
AHL is the most common sensory disorder in the elderly
and is considered a complex phenotype, but the respon-
sible heritable and nonheritable components are not well
quantified. Recent association studies have provided
candidate intervals for further studies.25,26
Considering the role of methionine sulfoxide reductases
in aging and age-related disorders, we hypothesized that
MSRB3 variants might be involved in AHL, and we tested
this hypothesis with an association study. We analyzed
1,040 Belgian volunteers aged 53–67 years who were ascer-
tained as part of a larger study described previously.16,17
Several audiological measures representing the hearing
ability of these individuals, corrected for age and sex,
were calculated on the basis of pure-tone audiometry. The
measures included Z scores for high frequencies18 and the
three main principal components, which account for26 The American Journal of Human Genetics 88, 19–29, January 7 , 285% of the variance.19 We selected these individuals to
represent the 20%extremes at both ends of the distribution
for each of the three principle components from a larger set
of individuals to maximize the power of the analysis. In
order to capture most of the genetic variation of MSRB3,
we selected 17 tagSNPs based on the HAPMAP data of
MSRB3 by using the default setting (r2 ¼ 0.8) of the Haplo-
view’s Tagger software.We performed an association test by
using linear regression with SPSS 15.0 for Windows (SPSS
inc., Chicago, Illinois, USA). The analyses of Z scores and
principal components showed no significant association
for any of theMSRB3 SNPs (Table S4). Although mutations
ofMSRB3 cause an autosomal-recessive Mendelian form of
nonsyndromic deafness, our data do not support a major
role for MSRB3 as a cause of human AHL in 53- to
67-year-old individuals of European origin.Discussion
Methionine sulfoxide reductases (Msr) catalyze the repair
of oxidized methionine in proteins by reducing methio-
nine sulfoxides (Met-SO) to the corresponding methio-
nines, thus preserving the biological activity of proteins
after oxidative damage due to reactive oxygen species.21
MSRB3 stereospecifically reduces methionine-R-sulfoxide
(Met-R-SO) to methionine.27,28 Malfunctions due to a011
mutation in MSRB3 might cause accumulation of oxida-
tively damaged proteins and reactive oxygen species
(ROS), which in turn might activate caspases and initiate
apoptosis or programmed cell death.29 Apoptosis plays
an essential role in normal development, morphogenesis,
and tissue homeostasis throughout the body, including
the inner ear.29–31 Mice homozygous for a targeted dele-
tion of caspase 3 display rapid hearing loss and profound
deafness by P30 as a result of the degeneration of inner
and outer hair cells and neurons in the spiral ganglion.30
Oxidative damage of proteins has been implicated in
normal aging and a variety of neurodegenerative age-
related diseases.32–37 A role for MSRA in the pathogenesis
of Alzheimer (MIM 104300) and Parkinson (MIM 168600)
diseases has been proposed.33,35,38 Furthermore, it has
been suggested that oxidative damage and mitochondrial
dysfunction have a role in the pathogenesis of cataracts
(MIM 212500) and age-related macular degeneration
(MIM 603075).39–43 Although we did not observe any asso-
ciation between 17 tagSNPS for MSRB3 and age-related
hearing loss in a cohort 1,040 50- to 70-year old individuals
of European ancestry, we do show that a recessive nonsense
mutation ofMSRB3 causing deafness ablates themitochon-
drial targeted isoform of MSRB3, whereas a missense muta-
tion is a null allele for all isoforms ofMSRB3.
The c.265T>G mutation of MSRB3 results in the substi-
tution of glycine for the cysteine at amino acid residue
89. This cysteine residue corresponds to p.Cys54 of
Drosophila and p.Cys48 of E. coli. Substitution of p.Cys54
in Drosophila and p.Cys48 in E. coli MSRB3 resulted in
a complete loss of metal binding and catalytic activity.44,45
These studies suggest that the introduction or removal of
Zn2þ in MSRB changes protein structure, which in turn
modulates catalytic activity and thermal stability.45 There-
fore, we hypothesized that the DFNB74 mutation alters or
ablates zinc binding and eliminates reductase activity of
this enzyme.44,45
The c.55C>T mutation found in two DFNB74 families
results in a premature translation stop codon (p.Arg19X).
This mutation is present within exon 3, encoding the
mitochondrial localization signal of isoforms B, C, and D,
indicating that at least one of the mitochondrial targeted
isoformsofMSRB3 is essential for hearing inhumans. There
is another example wherein mutations of a nuclear-
encoded gene altering mitochondrial function result in
hearing loss. X-linked recessive mutations of TIMM8A are
associated with deafness-dystonia-optic atrophy syndrome
(Mohr-Tranebjaerg syndrome,MIM 300356), characterized
by deafness, myopia, constriction of the visual field, and
dystonia. Mutations of TIMM8A alter a nuclear-encoded
mitochondrial inner-membrane complex essential for
protein-import into mitochondria.46–49
In summary, an in vitro assay revealed that p.Cys89Gly
completely abolished MSRB3 enzymatic activity and that
p.Arg19X is a null allele for MSRB3 mitochondrial iso-
forms, indicating that DFNB74 deafness might be a mito-
chondrial disease limited to the inner ear. Despite theThe Amexpression of MSRB3 isoforms in many cell types beyond
the inner ear, null alleles ofMSRB3 appear to be associated
only with nonsyndromic hearing loss. How some cells
compensate for the absence of MSRB3 function is an unan-
swered question. An animal model will be needed to reveal
the exact pathophysiological causes of deafness due to null
alleles of MSRB3 as well as the mechanism by which many
cells escape the absence of functional MSRB3.
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